REPORT: Monsanto is set to reject a $62 billion takeover offer
The agrochemical company is set to reject a $62 billion takeover offer from the German pharmaceutical giant Bayer, according to Reuters.
Bayer announced the unsolicited offer on Monday.
The $122-a-share offer was a 37% premium to Monsanto's share price before news broke of Bayer's interest.
Bayer CEO Werner Baumann on Monday said, "We fully expect a positive answer of the Monsanto board of directors."
Monsanto has not publicly commented on the takeover offer since Bayer named its price. It did acknowledge the receipt of a takeover offer last week in response to media reports that an offer existed.
Morgan Stanley and the boutique bank Ducera are advising Monsanto, while Credit Suisse, Bank of America, and Rothschild are advising Bayer.
BREAKING: Monsanto to reject Bayer's $122-per-share bid, seeks higher price
- Thailand is now welcoming Indians with open arms, but are its drought-hit islands really prepared for a tourism influx?
- Thoughtful gift ideas to make Mother's Day extra special
- Muslims up, Hindus down: What’s the larger picture behind India’s religious population trends?
- Scooch over magic mushrooms, toad venom could be the next big psychedelic for depression and anxiety!
- TBO Tek IPO allotment – How to check allotment, GMP, listing date and more
- Nothing Phone (2a) blue edition launched
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market